References
- Strand LM, Morley PC, Cipolle RJ, et al. Drug related problems: their
structure and function. DICP. 1990; 24: 1093e7.
- Johnson JA, Bootman JL. Drug-related morbidity and mortality. A
cost-of-illness model. Arch Intern Med. 1995; 155: 1949e56.
- http://www.un.org/esa/population/publications/worldageing19502050.
Assessed 19 September 2011.
- Caratozzolo S, Gipponi S, Marengoni A, et al.
Potentially
serious drug–drug interactions in older patients hospitalized for
acute ischemic and hemorrhagic stroke. Eur Neurol. 2016; 76: 161–6.
- Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am
J Geriatr Pharmacother. 2007; 5(4): 345–351.
- Simonson W, Feinberg JL. Medication-related problems in the elderly:
defining the issues and identifying solutions. Drugs Aging. 2005; 22:
559e69.
- Steinman MA, Hanlon JT. Managing medications in clinically complex
elders: “There’s got to be a happy medium”. JAMA. 2010; 304:
1592e601.
- St Peter WL, Wazny LD, Patel UD. New models of chronic kidney disease
care including pharmacists: improving medication reconciliation and
medication management. Current opinion in nephrology and hypertension.
2013; 22(6): 656-62.
- Guignard B, Bonnabry P, Perrier A, et al. Drug-related problems
identification in general internal medicine: the impact and role of
the clinical pharmacist and pharmacologist. Eur J Intern Med. 2015;
26: 399-406.
- Theising KM, Fritschle TL, Scholfield AM, et al. Implementation and
clinical outcomes of an employer-sponsored, pharmacist-provided
medication therapy management program. Pharmacotherapy. 2015; 35(11):
e159–63.
- Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure
control through pharmacist interventions: a meta-analysis of
randomized controlled trials. J Am Heart Ass. 2014; 3 (2): e000718.
- Ryan R, Santesso N, Lowe D, et al.
Interventions to improve safe and
effective medicines use by consumers: an overview of systematic
reviews. Cochrane Database Syst Rev. 2014; 4:CD007768.
- American Pharmacists Association and the National Association of Chain
Drug Stores Foundation. Medication therapy management in pharmacy
practice: Core elements of an MTM service model (version 2.0). J Am
Pharm Assoc (2003). 2008; (48): 3.
- Bluml BM. Definition of medication therapy management: development of
professionwide consensus. J Am Pharm Assoc (2003). 2005; 45 (5):
566–572.
- Pharmaceutical Care Network Europe Foundation. PCNE Classification for
drug related problems version 8.03. 2019.
https://www.pcne.org/upload/files/318_PCNE_classification_V8-03.pdf
- Stafford AC, Tenni PC, Peterson GM, et al. Drug-related problems
identified in medication reviews by Australian pharmacists. Pharm
World Sci. 2009; 31(2): 216–23.
- Rhalimi M, Rauss A, Housieaux E. Drug-related problems identified
during geriatric medication review in the community pharmacy. Int J
Clin Pharm. 2018; 40 (1):109–118.
- Kwint HF, Faber A, Gussekloo J, et al. The contribution of patient
interviews to the identification of drug-related problems in home
medication review. J Clin Pharm Ther. 2012; 37 (6):674–680.
- Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic
ulcer associated with individual non-steroidal anti-inflammatory
drugs. Lancet. 1994; 343: 1075–8.
- Bleumink GS, Feenstra J, Sturkenboom MC, et al. Nonsteroidal
anti-inflammatory drugs and heart failure. Drugs. 2003; 63: 525–34.
- H.T. Dougall, J. McLay. A comparative review of the adverse effects of
calcium antagonists. Drug Saf. 15 (1996), pp. 91-106.
- Hsu S, Ton VK, Dominique Ashen M, et al. A clinician’s guide to the
ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone
Center for the Prevention of Heart Disease and American College of
Cardiology Cardiosource Approach to the Million Hearts Initiative.
Clin Cardiol. 2013; 36(7):383–93.
- Ruano-Ravina A, Pena-Gil C, Abu-Assi E, et al. Participation and
adherence to cardiac rehabilitation programs. A systematic review. Int
J Cardiol. 2016; 223: 436-43.
- Amsterdam, Wenger, Brindis, et al. 2014 AHA/ACC Guideline for the
management of patients with non–ST-elevation acute coronary
syndromes: a report of the American College of Cardiology/American
Heart Association Task Force on practice guidelines. Circulation.
2014; 130: e344-e426.
- O’Gara, Ascheim, Donald E., et al. 2013 ACCF/AHA Guideline for the
management of ST-elevation myocardial infarction :a report of the
American College of Cardiology Foundation/American Heart Association
Task Force on practice guidelines. Circulation. 2013; 127: e362-e425.
- Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of
acute myocardial infarction in patients presenting with ST- segment
elevation: The Task Force on the management of ST-segment elevation
acute myocardial infarction of the European Society of Cardiology
(ESC). European heart journal. 2012; 33 (20):2569-619.
- Alsabbagh MW, Lemstra M, Eurich D, et
al.
Pharmacist Intervention in Cardiac Rehabilitation. Journal of
cardiopulmonary rehabilitation and prevention. 2012; 32 (6):394-9.
- Al-Baghdadi H, Koca Al-Baghdadi Ç, Abdi A, et al. Introducing clinical
pharmacy services to cardiovascular clinics at a university hospital
in Northern Cyprus. Int J Clin Pharm. 2017; 39 (6):1185–1193.
- Chau SH, Jansen AP, van de Ven PM, et al. Clinical medication reviews
in elderly patients with polypharmacy: a cross-sectional study on
drug-related problems in the Netherlands. Int J Clin Pharm. 2016; 38
(1): 46–53.
- Stegemann S, Ecker F, Maio M, et al. Geriatric drug therapy:
neglecting the inevitable majority. Ageing Res Rev. 2010; 9
(4):384–98.
- Chan DC, Chen JH, Wen CJ, et al. Effectiveness of the medication
safety review clinics for older adults prescribed multiple
medications. J Formos Med Assoc. 2014; 113 (2):106–13.
- Chan DC, Chen JH, Kuo HK, et al. Drug related problems (DRPs)
identified from geriatric medication safety review clinics. Arch
Gerontol Geriatr. 2012; 54 (1):168–74.
- Salvi F, Marchetti A, D’Angelo F, et al. Adverse drug events as a
cause of hospitalization in older adults. Drug Saf. 2012; 35: 29–45.
- Johnell K, Klarin I. The relationship between number of drugs and
potential drug-drug interactions in the elderly. Drug Saf. 2007; 30:
911–8.
- Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined
is an indicator of limited value in the assessment of drug-related
problems. Br J Clin Pharmacol. 2007; 63 (2):187–95.
- Hsu WT, Shen LJ, Lee CM. Drug-related problems vary with medication
category and treatment duration in Taiwanese heart failure outpatients
receiving case management. J Formos Med Assoc. 2016; 115 (5):335–342.
- Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic
outcomes of medication therapy management services: the Minnesota
experience. J Am Pharm Assoc (2003). 2008; 48 (2):203–211.
- Theising KM, Fritschle TL, Scholfield AM, et al. Implementation and
Clinical Outcomes of an Employer-Sponsored, Pharmacist-Provided
Medication Therapy Management Program. Pharmacotherapy. 2015; 35 (11):
e159–e163.
- Cheema E, Sutcliffe P, Singer DR. The impact of interventions by
pharmacists in community pharmacies on control of hypertension: a
systematic review and meta-analysis of randomized controlled
trials. Br J Clin Pharmacol. 2014; 78 (6):1238–1247.
- Lin HW, Lin CH, Chang CK, et al. Economic outcomes of
pharmacist-physician medication therapy management for polypharmacy
elderly: A prospective, randomized, controlled trial. J Formos Med
Assoc. 2018; 117 (3):235–243.